A. Semilietof

Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer

Brian J. Stevenson, D. Torigian, H. Nisenbaum, 2018, Science Translational Medicine.

Low Avidity T Cells Do Not Hinder High Avidity T Cell Responses Against Melanoma

D. Speiser, P. Baumgaertner, D. Vanhecke, 2019, Front. Immunol..

TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancer

N. Guex, I. Xenarios, G. Coukos, 2015, Oncoimmunology.

The NAD-Booster Nicotinamide Riboside Potently Stimulates Hematopoiesis through Increased Mitochondrial Clearance.

O. Naveiras, J. Auwerx, G. Coukos, 2019, Cell stem cell.

Biogenesis of HLA Ligand Presentation in Immune Cells Upon Activation Reveals Changes in Peptide Length Preference

Markus Müller, G. Coukos, M. Bassani-Sternberg, 2020, Frontiers in Immunology.

Combination of NY-ESO-1-TCR-T-cells coengineered to secrete SiRPα decoys with anti-tumor antibodies to augment macrophage phagocytosis

G. Coukos, V. Zoete, O. Michielin, 2023, bioRxiv.

Combining SiRPα decoy–coengineered T cells and antibodies augments macrophage-mediated phagocytosis of tumor cells

V. Zoete, O. Michielin, R. Sandaltzopoulos, 2024, The Journal of clinical investigation.